CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 6 incoming connections
- ScaleLevered free cash flow is $49.8M, above the global median of $16.24M
- FinancialsAltman Z-Score 4.04: safe zone
- Interpretations5 currently firing — 5
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.49%
Annual Rate
USD 0.14Paid quarterly
Payout Ratio
19.1%Sustainable
Consecutive Growth
2 yr
Paying Dividends
5 yr
Last Ex-Dividend
May 18, 2026
Last Payment
May 29, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
832.05MUSDvs all stocks (USD)
Trailing P/E
43.19xvs Health Information Services peers
Revenue (TTM)
311.78MUSDvs all stocks (USD)
Profit Margin
6.39%vs Health Information Services peers
Beta
0.4500xvs all stocks
52-Week Change
5.91%vs all stocks
Forward Annual Dividend Yield
0.49%vs all stocks
Market Capitalization
832.05MUSDvs all stocks (USD)
Enterprise Value
772.90MUSDvs all stocks (USD)
Trailing P/E
43.19xvs Health Information Services peers
Forward P/E
33.46xvs Health Information Services peers
PEG Ratio
1.01xPrice to Sales (TTM)
2.71xvs Health Information Services peers
Price to Book (MRQ)
2.41xvs Health Information Services peers
Enterprise to Revenue
2.48xvs Health Information Services peers
Enterprise to EBITDA
18.38xvs Health Information Services peers
Gross Margin
65.82%vs Health Information Services peers
Profit Margin
6.39%vs Health Information Services peers
Operating Margin
9.25%vs Health Information Services peers
Return on Assets (TTM)
2.84%vs Health Information Services peers
Return on Equity (TTM)
5.57%vs Health Information Services peers
Revenue (TTM)
311.78MUSDvs all stocks (USD)
Revenue per Share (TTM)
10.48USDUpdated Jul 19, 2026Quarterly Revenue Growth
10.50%vs Health Information Services peers
Gross Profit (TTM)
202.30MUSDvs all stocks (USD)
EBITDA (TTM)
67.46MUSDvs all stocks (USD)
Net Income (TTM)
19.92MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
36.40%vs Health Information Services peers
Operating Cash Flow (TTM)
63.38MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
49.80MUSDvs all stocks (USD)
Forward Annual Dividend Rate
0.1400USDUpdated Jul 19, 2026Forward Annual Dividend Yield
0.49%vs all stocks
Trailing Annual Dividend Rate
0.1320USDUpdated Jul 19, 2026Trailing Annual Dividend Yield
0.46%vs all stocks
Payout Ratio
19.10%vs Health Information Services peers
Revenue
304.06MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
107.21MUSDFY2025 · Dec 31, 2025Gross Profit
196.85MUSDFY2025 · Dec 31, 2025Operating Income
20.24MUSDvs all stocks (USD)
Pre-tax Income
23.22MUSDFY2025 · Dec 31, 2025Income Tax Expense
4.88MUSDFY2025 · Dec 31, 2025Net Income
18.34MUSDFY2025 · Dec 31, 2025EBIT
20.24MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
63.71MUSDFY2025 · Dec 31, 2025Research & Development
50.98MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
82.16MUSDFY2025 · Dec 31, 2025Non-operating Interest Income
3.34MUSDFY2025 · Dec 31, 2025EPS (Basic)
0.6100USDFY2025 · Dec 31, 2025EPS (Diluted)
0.6100USDFY2025 · Dec 31, 2025Basic Shares Outstanding
30.02MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
30.02MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
18.34MUSDFY2025 · Dec 31, 2025Operating Cash Flow
62.68MUSDFY2025 · Dec 31, 2025Free Cash Flow
59.03MUSDDerived from operating cash flow minus capital expenditure. This filing charges 43.48M of depreciation against 3.64M of capital expenditure, and its own free-cash-flow line reads 31.16M.FY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
36.16MUSDFY2025 · Dec 31, 2025Interest Paid
101.00KUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
18.34MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
43.48MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
5.12MUSDFY2025 · Dec 31, 2025Stock-based Compensation
8.14MUSDFY2025 · Dec 31, 2025Other Non-cash Items
11.32MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-3.98MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
1.42MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-21.16MUSDFY2025 · Dec 31, 2025Capital Expenditures
-3.64MUSDFY2025 · Dec 31, 2025Net Acquisitions
-35.09MUSDFY2025 · Dec 31, 2025Purchase of Investments
-45.00MUSDFY2025 · Dec 31, 2025Sale of Investments
61.86MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-21.88MUSDFY2025 · Dec 31, 2025Common Stock Repurchase
-30.02MUSDFY2025 · Dec 31, 2025Common Dividends Paid
-3.73MUSDFY2025 · Dec 31, 2025Other Financing Charges
-2.52MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-36.27MUSDFY2025 · Dec 31, 2025Shares Outstanding
29.30MSharesUpdated Jul 19, 2026Float Shares
23.20MSharesUpdated Jul 19, 2026Shares Short
1.05MSharesUpdated Jul 19, 2026Short Ratio
4.59daysvs all stocks
Short % of Shares Outstanding
5.38%vs all stocks
% Held by Insiders
20.46%vs all stocks
% Held by Institutions
75.64%vs all stocks
Total Cash (MRQ)
66.50MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
2.28USDUpdated Jul 19, 2026Total Debt (MRQ)
14.07MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.0400xvs Health Information Services peers
Current Ratio (MRQ)
0.9740xvs Health Information Services peers
Book Value per Share (MRQ)
12.01USDUpdated Jul 19, 2026Total Assets
520.37MUSDvs all stocks (USD)
Total Current Assets
119.66MUSDFY2025 · Dec 31, 2025Total Liabilities
166.35MUSDFY2025 · Dec 31, 2025Total Non-current Assets
400.72MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
42.20MUSDFY2025 · Dec 31, 2025Total Current Liabilities
124.15MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
36.16MUSDFY2025 · Dec 31, 2025Other Short-term Investments
20.84MUSDFY2025 · Dec 31, 2025Accounts Receivable
32.15MUSDFY2025 · Dec 31, 2025Accounts Payable
7.77MUSDFY2025 · Dec 31, 2025Deferred Revenue
88.42MUSDFY2025 · Dec 31, 2025Long-term Debt
14.68MUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
7.93MUSDFY2025 · Dec 31, 2025Common Stock (Book)
231.80MUSDFY2025 · Dec 31, 2025Retained Earnings
123.59MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
354.02MUSDvs all stocks (USD)
52-Week Low
19.50USDUpdated Jul 19, 202652-Week High
30.00USDUpdated Jul 19, 202652-Week Change
5.91%vs all stocks
Beta
0.4500xvs all stocks
50-Day MA
25.52USDUpdated Jul 19, 2026200-Day MA
23.65USDUpdated Jul 19, 2026Avg 10-Day Volume
156.73KSharesUpdated Jul 19, 2026Avg 30-Day Volume
201.94KSharesUpdated Jul 19, 2026Diluted EPS (TTM)
0.6700USDUpdated Jul 19, 2026Other Income / Expense
-358.00KUSDFY2025 · Dec 31, 20255 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Diagnostic
Goodwill-Heavy Equity
Equity looks heavy for the industry, but much of it is goodwill from past acquisitions.
Reads
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
Multi-Year Debt Decrease With Cash Near Total Debt And Equity
Long-term debt down in each of four years, and cash now covers most or all of what is left.
Reads
How does this company use capital?
FCF Ratios Elevated
Its free cash flow is large next to assets and equity, and more of its operating cash reaches it than in its industry.
Reads
Is this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.66Profit Margin: 0.06
Financial Health
Altman Z-Score 4.04: safe zoneNotable
Altman Z-Score: 4.04
High earnings qualityNotable
Earnings Quality Score: 3.13
Supply Chain
Midstream position: 5 outgoing, 6 incoming connectionsNotable
Outgoing: 5.00Incoming: 6.00
High connectivity hub: 11 industry connectionsNotable
Total Connections: 11.00
Scale
Levered free cash flow is $49.8M, above the global median of $16.24MNotable
Levered free cash flow (USD): 49,804,624Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Nsfocus Technologies Group Co. Ltd.
Tier 1ProductionRecurring-Revenue Lock-InSenseMakingRule
Beijing Join-Cheer Software Co., Ltd.
Tier 1ProductionRecurring-Revenue Lock-InInterfaceFlow
Fujian Foxit Software Development Co., Ltd.
Tier 1ProductionRecurring-Revenue Lock-InFlowRule
Ucap Cloud Information Technology Co., Ltd.
Tier 1ProductionRecurring-Revenue Lock-InFlowInterface
Beijing CTJ Information Technology Co., Ltd.
Tier 1ProductionRecurring-Revenue Lock-InSenseMakingInterface
Life Semantics Corp
Tier 1ProductionRecurring-Revenue Lock-InInterfaceFlow
B-Soft Co., Ltd.
Tier 1ProductionRecurring-Revenue Lock-InFlowRule
Newgen Software Technologies Ltd.
Tier 1ProductionRecurring-Revenue Lock-InInterfaceSenseMaking
Sichuan Jiuyuan Yinhai Software Co., Ltd.
Tier 1ProductionRecurring-Revenue Lock-InFlowInterface
Ming Yuan Cloud Group Holdings Limited
Tier 1ProductionRecurring-Revenue Lock-InFlowInterface
Companies that share active interpretations — structural patterns currently present in both stocks.
Harmony Biosciences Holdings, Inc.
4 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesFCF Ratios ElevatedMulti-Year Revenue, Profit, And Income GrowthMulti-Year Debt Decrease With Cash Near Total Debt And Equity
Regeneron Pharmaceuticals, Inc.
3 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesFCF Ratios ElevatedMulti-Year Revenue, Profit, And Income Growth
Strategic Education Inc.
4 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesMulti-Year Revenue, Profit, And Income GrowthGoodwill-Heavy EquityMulti-Year Debt Decrease With Cash Near Total Debt And Equity